<DOC>
	<DOC>NCT00855387</DOC>
	<brief_summary>The purpose of this study is to prospectively assess the impact of surgical quality on the overall cost of major surgical procedures using the incidence and severity of complications as surrogate markers of quality.</brief_summary>
	<brief_title>Severe Complications Triplicate the Costs of Major Surgical Procedures</brief_title>
	<detailed_description>To prospectively assess the impact of surgical quality on the overall cost of major surgical procedures using the incidence and severity of complications as surrogate markers of quality</detailed_description>
	<mesh_term>Pancrelipase</mesh_term>
	<mesh_term>Pancreatin</mesh_term>
	<criteria>Undergoing major surgery (liver, bile duct, pancreas, colorectal, gastric bypass and small bowel resections) Missing data of inhospital costs Mortality</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Clinical outcome (complications), in-hospital costs</keyword>
	<keyword>The influence and impact of postoperative complications on in-hospital costs</keyword>
</DOC>